Results
Counterpart Assistant (CA) was incubated by Clover Health as Clover Assistant, and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology.
Clinical Quality and HEDIS®
Counterpart Health has helped empower Clover Health's PPO plans to enhance care quality and achieve 4.94 out of 5 Stars on HEDIS measures for Star Rating year 2025 through a technology-driven approach to value-based care.¹
Medical Cost Ratio (MCR)
Double-digit MCR differential for returning members whose PCPs use Counterpart Assistant as compared to those who do not. ⁶
Chronic Obstructive Pulmonary Disease
A relationship with a PCP that uses CA is correlated with better outcomes for COPD patients, including fewer hospitalizations and readmissions, and better clinical management, such as more frequent outpatient pulmonology visits.
Heart Failure
A relationship with a PCP that uses CA is associated with better outcomes for CHF patients, including fewer hospitalizations and readmissions, and better clinical management, such as more frequent outpatient cardiologist visits and in-home care.
Diabetes
CA use is associated with early diagnosis, early treatment, improved blood sugar control, lower insulin use, and lower instances of Hypoglycemia.
Chronic Kidney Disease (CKD)
CA use is associated with early diagnosis and improved disease trajectory.
Medication Adherence
CA use correlated with increased medication fills in previously non-adherent patients and higher performance on medication adherence quality measures.
Underserved Patient Populations
Patients from disadvantaged neighborhoods with a Counterpart Assistant PCP showed a higher frequency of new diagnoses (diabetes, CKD, CHF, or COPD) during their first year and were first diagnosed with CKD and diabetes at earlier clinical stages.
